Please assess the completion status of the following clinical trial:

Trial Title: Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of written informed consent before starting the study-related procedures and examinations~* Patients who have the history of gastric and/or duodenal ulcer.~* A diagnosis of a chronic condition (angina pectoris, myocardial infarction and ischemic cerebrovascular disorder, etc., requiring prevention of thrombosis or embolism) which requires taking the prescribed LDA during the study treatment period.~Exclusion Criteria:~* Having gastric or duodenal ulcer (except for ulcer scar).~* History of esophageal, gastric or duodenal surgery, except for simple closure of perforation.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Esomeprazole 20mg (Type: EXPERIMENTAL): Esomeprazole 20mg once daily oral
- Placebo (Type: PLACEBO_COMPARATOR): Placebo once daily oral

Based on this trial design, predict the completion outcome and termination type (if applicable).